Characteristics and Mechanism of Acute Ischemic Stroke in NAVF Patients With Prior Oral Anticoagulant Therapy

被引:1
|
作者
Xue, Sufang [1 ]
Na, Risu [2 ]
Dong, Jing [1 ]
Wei, Min [1 ]
Kong, Qi [1 ]
Wang, Qiujia [1 ]
Qiu, Xue [3 ]
Li, Fangyu [1 ]
Song, Haiqing [1 ,4 ]
机构
[1] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Beijing, Peoples R China
[2] Tongliao City Hosp, Dept Neurol, Tongliao, Peoples R China
[3] Shuangqiao Hosp, Dept Neurol, Beijing, Peoples R China
[4] Capital Med Univ, Xuanwu Hosp, Dept Neurol, Changchun St 45, Beijing 100053, Peoples R China
关键词
prior oral anticoagulant therapy; acute ischemic stroke; nonvalvular atrial fibrillation; competing stroke mechanism; CAROTID-ARTERY STENOSIS; ATRIAL-FIBRILLATION; PREDICTING STROKE; SUBGROUP ANALYSIS; PREVENTION; WARFARIN; RISK; CLASSIFICATION; VALIDATION; RECURRENCE;
D O I
10.1097/NRL.0000000000000504
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: We aimed to analyze the characteristics and mechanisms of acute ischemic stroke (AIS) in patients with nonvalvular atrial fibrillation (NVAF) who received prior anticoagulant therapy.Methods: We retrospectively analyzed the data of patients with NVAF and AIS between January 2016 and December 2021. Patients were divided into non-anticoagulant, adequate anticoagulant, and insufficient anticoagulant groups according to their prior anticoagulant status. Patients with prior anticoagulant therapy were further divided into warfarin and direct oral anticoagulant groups.Results: A total of 749 patients (661 without anticoagulants, 33 with adequate anticoagulants, and 55 with insufficient anticoagulants) were included. Patients with adequate anticoagulant had a milder National Institute of Health Stroke Scale at presentation (P=0.001) and discharge (P=0.003), a higher proportion of Modified Rankin Scale (mRS) <= 2 at discharge (P=0.011), and lower rates of massive infarction (P=0.008) than patients without anticoagulant. Compared with the non-anticoagulant group, the proportion of intravenous thrombolysis was significantly lower in the adequate anticoagulant (P<0.001) and insufficient anticoagulant (P=0.009) groups. Patients in the adequate anticoagulant group had higher rates of responsible cerebral atherosclerotic stenosis (P=0.001 and 0.006, respectively) and competing large artery atherosclerotic mechanisms (P=0.006 and 0.009, respectively) than those in the other 2 groups. Compared with warfarin, direct oral anticoagulant was associated with higher rates of Modified Rankin Scale <= 2 at discharge (P=0.003).Conclusions: Adequate anticoagulant therapy may be associated with milder stroke severity and better outcomes at discharge in patients with NVAF. Competing large artery atherosclerotic mechanisms may be associated with anticoagulant failure in patients with NAVF with prior adequate anticoagulant therapy.
引用
收藏
页码:379 / 385
页数:7
相关论文
共 50 条
  • [31] CHA2DS2-VASc score and prior oral anticoagulant use on endovascular treatment for acute ischemic stroke
    Imaoka, Yukihiro
    Ren, Nice
    Ogata, Soshiro
    Imamura, Hirotoshi
    Kaku, Yasuyuki
    Arimura, Koichi
    Watanabe, Shogo
    Kiyoshige, Eri
    Nishimura, Kunihiro
    Kobashi, Syoji
    Ihara, Masafumi
    Kamiyama, Kenji
    Morimoto, Masafumi
    Ohta, Tsuyoshi
    Endo, Hidenori
    Matsumaru, Yuji
    Sakai, Nobuyuki
    Kitazono, Takanari
    Fujimoto, Shigeru
    Ogasawara, Kuniaki
    Iihara, Koji
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024,
  • [32] Preadmission oral anticoagulant therapy and clinical outcome in patients hospitalised with acute stroke and atrial fibrillation
    Ottosen, Tobias Pilgaard
    Svendsen, Marie Louise
    Hansen, Morten Lock
    Brandes, Axel
    Andersen, Grethe
    Husted, Steen Elkjaer
    Johnsen, Soren Paaske
    DANISH MEDICAL JOURNAL, 2014, 61 (09):
  • [33] Prior antiplatelet or anticoagulant therapy and mortality in stroke
    Kwok, Chun Shing
    Skinner, Jane
    Metcalf, Anthony K.
    Potter, John F.
    Myint, Phyo Kyaw
    HEART, 2012, 98 (09) : 712 - 717
  • [34] Oral anticoagulant therapy for the prevention of stroke
    Powers, WJ
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (20): : 1493 - 1495
  • [35] Thrombolytic therapy in patients with acute ischemic stroke
    Hinchey, JA
    Benesch, C
    ARCHIVES OF NEUROLOGY, 2000, 57 (10) : 1430 - 1436
  • [36] Safety of antiplatelet therapy prior to intravenous thrombolysis in acute ischemic stroke
    Uyttenboogaart, Maarten
    Koch, Marcus W.
    Koopman, Karen
    Vroomen, Patrick C. A. J.
    De Keyser, Jacques
    Luijckx, Gert-Jan
    ARCHIVES OF NEUROLOGY, 2008, 65 (05) : 607 - 611
  • [37] Anticoagulant therapy for ischemic stroke: A review of literature
    Shahpouri, Mohammad Mehdi
    Mousavi, Seyed Ali
    Khorvash, Faribourz
    Mousavi, Seyed Morteza
    Hoseini, Tahereh
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2012, 17 (04): : 396 - 401
  • [38] Thrombolysis outcomes in acute ischemic stroke patients with prior stroke and diabetes mellitus
    Mishra, N. K.
    Ahmed, N.
    Davalos, A.
    Iversen, H. K.
    Melo, T.
    Soinne, L.
    Wahlgren, N.
    Lees, K. R.
    NEUROLOGY, 2011, 77 (21) : 1866 - 1872
  • [39] SAFETY OF RECANALIZATION THERAPY IN ACUTE ISCHEMIC STROKE PATIENTS ON ANTICOAGULANT THERAPY: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS
    Kumar, P.
    Srivastava, A.
    Prasad, K.
    INTERNATIONAL JOURNAL OF STROKE, 2022, 17 (3_SUPPL) : 32 - 33
  • [40] Comparative Effectiveness of Addition of Antiplatelet to Oral Anticoagulant in Acute Ischemic Stroke With Atrial Fibrillation
    Kim, Joon-tae
    Bae, Hee-Joon
    STROKE, 2020, 51